These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34073648)

  • 1. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.
    Pippa N; Gazouli M; Pispas S
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.
    Gutjahr A; Phelip C; Coolen AL; Monge C; Boisgard AS; Paul S; Verrier B
    Vaccines (Basel); 2016 Oct; 4(4):. PubMed ID: 27754314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-adjuvanting cancer nanovaccines.
    Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
    J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.
    Vijayan V; Mohapatra A; Uthaman S; Park IK
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31615112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-Based Nanomaterials and Applications for Vaccines and Drugs.
    Han J; Zhao D; Li D; Wang X; Jin Z; Zhao K
    Polymers (Basel); 2018 Jan; 10(1):. PubMed ID: 30966075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.
    Joshi VB; Geary SM; Salem AK
    Hum Vaccin Immunother; 2013 Dec; 9(12):2584-90. PubMed ID: 23978910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
    Hafner AM; Corthésy B; Textor M; Merkle HP
    Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
    Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
    Front Immunol; 2017; 8():1077. PubMed ID: 28955328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
    Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
    Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobiomaterial-based vaccination immunotherapy of cancer.
    Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H
    Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of Nanovaccines for Disease Prevention in Cattle.
    Maina TW; Grego EA; Boggiatto PM; Sacco RE; Narasimhan B; McGill JL
    Front Bioeng Biotechnol; 2020; 8():608050. PubMed ID: 33363134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in peptide-based subunit nanovaccines.
    Skwarczynski M; Toth I
    Nanomedicine (Lond); 2014 Dec; 9(17):2657-69. PubMed ID: 25529569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.